anti-CD31 antibody product blog
Tags: Antibody; Monoclonal Antibody; CD31; anti-CD31 antibody;
The CD31 n/a (Catalog #MBS532339) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The CD31 antibody (biotin) reacts with Murine CD31 and may cross-react with other species as described in the data sheet. MyBioSource\'s CD31 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP). Researchers should empirically determine the suitability of the CD31 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rat monoclonal CD31 antibody (biotin).
Biological Significance: CD31 is a cluster of differentiation molecule. It is also called PECAM-1 for Platelet Endothelial Cell Adhesion Molecule. It plays a key role in removing aged neutrophils from the body. Macrophages palpate any passing neutrophil and have to decide whether the cell is healthy or has to be ingested. In humans, the gene encoding CD-31 is found on chromosome 17. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Tag/Conjugate: Biotin
Immunogen: CD31 antibody (biotin) was raised in rat using murine leukocyte cell line 32D as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD31 are readily searchable from our website. Different antibodies against the same target such as CD31 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.